Archer Investment Corp Buys 2,313 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Archer Investment Corp lifted its position in Roche Holding AG (OTCMKTS:RHHBYFree Report) by 59.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 6,228 shares of the company’s stock after purchasing an additional 2,313 shares during the quarter. Archer Investment Corp’s holdings in Roche were worth $211,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently modified their holdings of RHHBY. Chartwell Investment Partners LLC grew its holdings in Roche by 4.7% during the third quarter. Chartwell Investment Partners LLC now owns 112,858 shares of the company’s stock worth $3,862,000 after acquiring an additional 5,038 shares during the period. Motco grew its holdings in Roche by 612.7% during the third quarter. Motco now owns 4,426 shares of the company’s stock worth $151,000 after acquiring an additional 3,805 shares during the period. Tower Bridge Advisors purchased a new position in Roche during the third quarter worth approximately $2,811,000. Paradigm Asset Management Co. LLC lifted its position in Roche by 18.4% during the third quarter. Paradigm Asset Management Co. LLC now owns 5,151 shares of the company’s stock worth $175,000 after buying an additional 800 shares in the last quarter. Finally, Enterprise Financial Services Corp purchased a new position in Roche during the third quarter worth approximately $288,000.

Roche Trading Down 1.1 %

OTCMKTS:RHHBY opened at $33.95 on Monday. Roche Holding AG has a 52 week low of $31.77 and a 52 week high of $40.48. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.86 and a current ratio of 1.18. The stock’s fifty day moving average is $35.66 and its two-hundred day moving average is $35.46.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley downgraded Roche from an “equal weight” rating to an “underweight” rating in a research report on Tuesday, January 16th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Roche has an average rating of “Hold” and an average price target of $40.00.

View Our Latest Report on Roche

Roche Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation.

Read More

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBYFree Report).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.